The Recall Desk
SevereFDA (Drugs)·D-0320-2017·Announced 2017-01-11

Tri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns

Tri-Coast Pharmacy is recalling 2 units of TriMix injection because the agency cannot assure the products are sterile.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of serious injury or infection.

Plain-English summary

Tri-Coast Pharmacy is recalling 2 units of TriMix, a compounded medication containing Alprostadil, Phentolamine, and Papaverine. The recall is being conducted because the U.S. Food and Drug Administration cannot assure the sterility of the products.

The recall includes all sterile products compounded between May 17, 2016, and November 17, 2016. The known lot code is 08022016F, with an expiration date of December 8, 2016. The products were distributed nationwide.

Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
TriMix, Alprostadil/Phentolamine/Papaverine 100mcg/3mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy
Manufacturer
Tri-Coast Pharmacy
Affected units
2

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 80 products in this recall →